X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-06-04 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Officer | S - Sale | $12.31 | -275 | 130,612 | 0% | -$3,385 | ||||||
2026-06-04 | BBNX | Beta Bionics, Inc. | Jones Christy | Dir | S - Sale | $14.00 | -2,811 | 27,400 | -9% | -$39,354 | ||||||
2026-06-03 | RCEL | Avita Medical, Inc. | Woody Joseph Fralin | Dir | P - Purchase | $4.09 | +10,000 | 92,761 | +12% | +$40,949 | ||||||
2026-06-04 | NVCR | Novocure Ltd | Leonard Frank X | CEO | S - Sale | $17.93 | -34,273 | 459,520 | -7% | -$614,635 | ||||||
| M | 2026-06-03 | DXCM | Dexcom Inc | Coleman Jon | EVP, Chief Commercial Officer | S - Sale | $73.56 | -9,823 | 95,450 | -9% | -$722,628 | |||||
2026-06-03 | PODD | Insulet Corp | Stonesifer Timothy C. | Dir | P - Purchase | $143.51 | +2,790 | 9,041 | +45% | +$400,393 | ||||||
2026-06-03 | PODD | Insulet Corp | Borio Luciana | Dir | S - Sale | $143.27 | -418 | 4,329 | -9% | -$59,887 | ||||||
2026-06-04 | IRMD | Iradimed Corp | Scharen-Guivel Hilda Frederique | Dir | S - Sale | $95.00 | -3,000 | 5,598 | -35% | -$285,000 | ||||||
| M | 2025-06-30 | GIPL | Global Innovative Platforms Inc. | Brown David A B | 10% | P - Purchase | $0.03 | +6,682,800 | 3,775,612 | -230% | +$202,000 | |||||
2026-06-03 | DRTS | Alpha Tau Medical Ltd. | Levy Raphi | CFO | S - Sale | $10.83 | -32,500 | 147,680 | -18% | -$352,115 | ||||||
2026-06-01 | NXGL | Nexgel, Inc. | Levy Adam R. | CEO | S - Sale | $0.59 | -2,000 | 342,692 | -1% | -$1,172 | ||||||
2026-06-02 | BBNX | Beta Bionics, Inc. | Mensinger Mike | Chief Product Officer | S - Sale | $12.61 | -4,378 | 184,415 | -2% | -$55,194 | ||||||
2026-06-02 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Officer | S - Sale | $12.61 | -5,329 | 130,887 | -4% | -$67,183 | ||||||
2026-06-02 | BBNX | Beta Bionics, Inc. | Russell Steven Jon | Chief Medical Officer | S - Sale | $12.61 | -4,222 | 173,849 | -2% | -$53,227 | ||||||
2026-06-02 | BBNX | Beta Bionics, Inc. | Feider Stephen | CFO | S - Sale | $12.61 | -6,676 | 166,053 | -4% | -$84,165 | ||||||
2026-06-02 | BBNX | Beta Bionics, Inc. | Saint Sean | Pres, CEO | S - Sale | $12.61 | -16,872 | 420,937 | -4% | -$212,707 | ||||||
2026-06-02 | NVCR | Novocure Ltd | Leung Gabriel | Dir | S - Sale | $15.77 | -2,945 | 89,499 | -3% | -$46,445 | ||||||
2026-06-02 | NVCR | Novocure Ltd | Stafford Kristin | Dir | S - Sale | $15.77 | -2,945 | 11,324 | -21% | -$46,445 | ||||||
2026-06-02 | NVCR | Novocure Ltd | Ocean Allyson J | Dir | S - Sale | $15.77 | -2,945 | 11,324 | -21% | -$46,445 | ||||||
2026-06-02 | NVCR | Novocure Ltd | Scannell Timothy J | Dir | S - Sale | $15.77 | -2,945 | 14,288 | -17% | -$46,445 | ||||||
2026-06-02 | NVCR | Novocure Ltd | Hilleman Jeryl L | Dir | S - Sale | $15.77 | -2,945 | 13,861 | -18% | -$46,445 | ||||||
2026-06-02 | NVCR | Novocure Ltd | Vernon W Anthony | Dir | S - Sale | $15.77 | -2,945 | 197,657 | -1% | -$46,445 | ||||||
2026-06-02 | NVCR | Novocure Ltd | Hung David | Dir | S - Sale | $15.77 | -2,945 | 20,465 | -13% | -$46,445 | ||||||
| M | 2026-06-01 | RCEL | Avita Medical, Inc. | Woody Joseph Fralin | Dir | P - Purchase | $4.25 | +20,000 | 20,000 | New | +$84,937 | |||||
2026-06-03 | PODD | Insulet Corp | Weatherman Elizabeth H | Dir | P - Purchase | $144.20 | +3,450 | 10,352 | +50% | +$497,490 | ||||||
2026-06-01 | LUNG | Pulmonx Corp | Radhakrishnan Srikanth | Chief Science,Techn. Officer | S - Sale | $1.54 | -14,497 | 331,239 | -4% | -$22,325 | ||||||
2026-06-01 | LUNG | Pulmonx Corp | Lehman David Aaron | GC | S - Sale | $1.54 | -14,594 | 376,161 | -4% | -$22,475 | ||||||
2026-06-01 | LUNG | Pulmonx Corp | Rose Geoffrey Beran | Chief Commercial Officer | S - Sale | $1.54 | -8,023 | 457,711 | -2% | -$12,355 | ||||||
2026-06-02 | IRTC | Irhythm Holdings, Inc. | Shrishrimal Sumi | EVP, Chief Risk Officer | S - Sale | $108.19 | -1,716 | 40,287 | -4% | -$185,652 | ||||||
| M | 2026-06-01 | LUNG | Pulmonx Corp | French Glendon E. III | Pres, CEO | S - Sale | $1.55 | -56,149 | 2,096,360 | -3% | -$86,875 | |||||
2026-06-02 | IRTC | Irhythm Holdings, Inc. | Rosenbaum Marc Wade | Chief Accounting Officer | S - Sale | $108.19 | -729 | 16,155 | -4% | -$78,870 | ||||||
| M | 2026-06-01 | BWAY | Brainsway Ltd. | Roth Yiftach | Chief Scientist | S - Sale | $0.00 | -7,000 | 1,072,305 | -1% | -$0 | |||||
2026-06-01 | WOK | Work Medical Technology Group Ltd | Hrt Financial LP | 10% | P - Purchase | $0.14 | +2,746,332 | 0 | -100% | +$378,994 | ||||||
2026-06-02 | WOK | Work Medical Technology Group Ltd | Hrt Financial LP | 10% | S - Sale | $0.11 | -1,757,955 | 0 | -100% | -$188,101 | ||||||
| D | 2026-06-01 | BDX | Becton Dickinson & Co | Polen Thomas E Jr | COB, CEO, Pres | S - Sale+OE | $146.35 | -2,764 | 110,163 | -2% | -$404,511 | |||||
2026-05-29 | CERS | Cerus Corp | Jayaraman Vivek K | COO | S - Sale | $3.00 | -16,667 | 1,656,707 | -1% | -$50,001 | ||||||
2026-06-01 | CLPT | Clearpoint Neuro, Inc. | Richards Timothy T. | Dir | S - Sale | $12.17 | -5,415 | 87,198 | -6% | -$65,901 | ||||||
2026-06-01 | OBIO | Orchestra Biomed Holdings, Inc. | Hochman David P | See Remarks | P - Purchase | $3.83 | +5,000 | 1,512,651 | 0% | +$19,150 | ||||||
2026-06-01 | OBIO | Orchestra Biomed Holdings, Inc. | Sherman Darren | See Remarks | S - Sale | $3.87 | -15,000 | 1,184,327 | -1% | -$58,050 | ||||||
2026-05-29 | QTEX | Qtrex Quantum Ltd. | Yechezkely Hayon Daniella | CTO | S - Sale | $3.00 | -50,000 | 780,000 | -6% | -$150,000 | ||||||
| M | 2026-05-29 | QTEX | Qtrex Quantum Ltd. | Tehila Yafit | CFO | S - Sale | $3.50 | -30,000 | 870,000 | -3% | -$105,019 | |||||
2026-06-01 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $90.60 | -2,500 | 4,387,950 | 0% | -$226,507 | ||||||
2026-05-28 | MDLN | Medline Inc. | Hellman & Friedman Capital Partners X (Parallel), L.P. | 10% | S - Sale | $36.54 | -31,868,237 | 70,874,326 | -31% | -$1,164,385,709 | ||||||
| DM | 2026-05-28 | SIBN | Si-Bone, Inc. | Davis Timothy E Jr | Dir | S - Sale+OE | $14.31 | -7,280 | 65,722 | -10% | -$104,187 | |||||
2026-05-28 | WOK | Work Medical Technology Group Ltd | Hrt Financial LP | 10% | P - Purchase | $0.09 | +1,535,850 | 0 | -100% | +$138,227 | ||||||
2026-05-29 | WOK | Work Medical Technology Group Ltd | Hrt Financial LP | 10% | S - Sale | $0.10 | -2,619,607 | 0 | -100% | -$261,961 | ||||||
2026-06-01 | TMCI | Treace Medical Concepts, Inc. | Treace John T. | CEO, 10% | P - Purchase | $3.56 | +50,000 | 12,647,962 | 0% | +$177,915 | ||||||
2026-05-28 | MDLN | Medline Inc. | Bx Mozart Ml-2 Holdco L.P. | 10% | S - Sale | $36.54 | -33,317,824 | 1,990,467 | -94% | -$1,217,349,994 | ||||||
| M | 2026-05-27 | NXGL | Nexgel, Inc. | Levy Adam R. | CEO | S - Sale | $0.60 | -13,000 | 344,692 | -4% | -$7,834 | |||||
2026-05-28 | SYK | Stryker Corp | Fletcher Robert S | VP, GC | S - Sale | $306.87 | -4,544 | 10,765 | -30% | -$1,394,409 | ||||||
2026-05-27 | NSPR | Inspiremd, Inc. | Stuka Paul | Dir | P - Purchase | $0.88 | +20,000 | 1,091,575 | +2% | +$17,500 | ||||||
| DM | 2026-05-27 | QTEX | Qtrex Quantum Ltd. | Tehila Yafit | CFO | S - Sale+OE | $2.40 | -60,000 | 900,000 | -6% | -$143,961 | |||||
2026-05-26 | SYK | Stryker Corp | Stryker Ronda E | Dir | S - Sale | $312.23 | -310,000 | 14,817,258 | -2% | -$96,792,669 | ||||||
| M | 2026-05-26 | TMCI | Treace Medical Concepts, Inc. | Treace John T. | CEO, 10% | P - Purchase | $2.95 | +115,520 | 12,597,962 | +1% | +$340,589 | |||||
| M | 2026-05-26 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $92.14 | -7,500 | 2,165,000 | 0% | -$691,044 | |||||
2026-05-26 | BDX | Becton Dickinson & Co | Feld Michael | EVP, Chief Revenue Officer | S - Sale | $147.35 | -75 | 21,084 | 0% | -$11,051 | ||||||
| M | 2026-05-21 | PDEX | Pro Dex Inc | Van Kirk Richard Lee Jr | CEO | S - Sale | $62.62 | -10,000 | 89,707 | -10% | -$626,248 | |||||
2026-05-21 | BBNX | Beta Bionics, Inc. | Jones Christy | Dir | S - Sale | $9.95 | -1,998 | 30,211 | -6% | -$19,880 | ||||||
| M | 2026-05-21 | BBNX | Beta Bionics, Inc. | Lezack Adam | Dir | S - Sale | $10.58 | -1,998 | 55,796 | -3% | -$21,138 | |||||
| D | 2026-05-21 | CLPT | Clearpoint Neuro, Inc. | Klein Matthew B. | Dir | S - Sale+OE | $11.59 | -16,000 | 46,935 | -25% | -$185,440 | |||||
2026-05-21 | DXCM | Dexcom Inc | Sayer Kevin R | Exec Chair | S - Sale | $72.00 | -26,759 | 382,482 | -7% | -$1,926,648 | ||||||
2026-05-22 | PETV | Petvivo Holdings, Inc. | A.L. Sarroff Fund, LLC | 10% | P - Purchase | $0.40 | +250,000 | 10,452,229 | +2% | +$100,000 | ||||||
| M | 2026-05-25 | BWAY | Brainsway Ltd. | Mitrany Rayten Michal Ety | Dir | S - Sale | $0.00 | -17,980 | 12,500 | -59% | -$0 | |||||
2026-05-22 | ICUI | Icu Medical Inc/De | Woolson Daniel | Pres | S - Sale | $132.21 | -2,123 | 22,479 | -9% | -$280,685 | ||||||
2026-05-20 | ATRC | Atricure, Inc. | Prange Karen | Dir | S - Sale | $28.65 | -3,000 | 26,373 | -10% | -$85,950 | ||||||
2026-05-20 | BSX | Boston Scientific Corp | Pegus Cheryl | Dir | P - Purchase | $56.49 | +1,770 | 1,770 | New | +$99,987 | ||||||
2026-05-20 | BSX | Boston Scientific Corp | Ludwig Edward J | Dir | P - Purchase | $56.68 | +3,580 | 25,359 | +16% | +$202,914 | ||||||
| M | 2026-05-19 | BSX | Boston Scientific Corp | Habiger David C | Dir | P - Purchase | $56.43 | +4,450 | 13,878 | +47% | +$251,098 | |||||
| M | 2025-01-27 | NSPR | Inspiremd, Inc. | Gleason Shane Thomas | Chief Commercial Officer | S - Sale | $2.22 | -85,295 | 1,053,882 | -7% | -$189,594 | |||||
| D | 2026-05-20 | CLPT | Clearpoint Neuro, Inc. | Fallon Lynnette C | Dir | S - Sale+OE | $11.14 | -5,091 | 48,227 | -10% | -$56,714 | |||||
2026-05-20 | LUCD | Lucid Diagnostics Inc. | Matheis Dennis | Dir | P - Purchase | $1.00 | +245,000 | 1,033,443 | +31% | +$245,270 | ||||||
| A | 2026-03-19 | STIM | Neuronetics, Inc. | Pfanstiel Steven | Former EVP, CFO, Treasurer | S - Sale | $1.34 | -8,569 | 836,643 | -1% | -$11,482 | |||||
| D | 2026-05-18 | HTFL | Heartflow, Inc. | Rogers Campbell | Chief Medical Officer | S - Sale+OE | $28.34 | -9,219 | 224,271 | -4% | -$261,266 | |||||
2026-05-18 | KRMD | Koru Medical Systems, Inc. | Schiller Eric | CTO | P - Purchase | $3.91 | +5,000 | 5,000 | New | +$19,563 | ||||||
| M | 2026-05-18 | IRMD | Iradimed Corp | Susi Roger E. | CEO, Pres, COB, 10% | S - Sale | $87.64 | -7,500 | 4,397,950 | 0% | -$657,265 | |||||
2026-05-18 | SIBN | Si-Bone, Inc. | Francis Laura | CEO | S - Sale | $14.71 | -14,957 | 882,126 | -2% | -$220,000 | ||||||
2026-05-18 | SIBN | Si-Bone, Inc. | Pisetsky Michael A. | SVP, Ops, Adm, Chief Legal Ofr | S - Sale | $14.63 | -3,726 | 280,509 | -1% | -$54,527 | ||||||
2026-05-20 | RCEL | Avita Medical, Inc. | O'Toole David D | CFO | P - Purchase | $4.26 | +2,000 | 145,927 | +1% | +$8,520 | ||||||
2026-05-18 | SIBN | Si-Bone, Inc. | Maheshwari Anshul | CFO | S - Sale | $14.69 | -4,666 | 259,877 | -2% | -$68,523 | ||||||
| A | 2026-05-15 | KRMD | Koru Medical Systems, Inc. | Tharby Linda M | CEO | P - Purchase | $3.92 | +1,191 | 620,622 | 0% | +$4,669 | |||||
| E | 2026-05-15 | KRMD | Koru Medical Systems, Inc. | Tharby Linda M | CEO | P - Purchase | $1.00 | +1,191 | 620,622 | 0% | +$1,191 | |||||
2026-05-19 | STIM | Neuronetics, Inc. | Chernett Jorey | 10% | P - Purchase | $1.17 | +100,000 | 10,553,988 | +1% | +$117,000 | ||||||
2026-05-18 | OBIO | Orchestra Biomed Holdings, Inc. | Aryeh Jason | Dir | P - Purchase | $3.75 | +665 | 118,118 | +1% | +$2,494 | ||||||
2026-05-18 | SGHT | Sight Sciences, Inc. | Bauerlein Alison | COO | S - Sale | $5.12 | -12,728 | 688,893 | -2% | -$65,167 | ||||||
2026-05-15 | DXCM | Dexcom Inc | Brown Michael Jon | EVP, GC | S - Sale | $59.91 | -1,700 | 109,504 | -2% | -$101,847 | ||||||
2026-05-19 | RCEL | Avita Medical, Inc. | O'Toole David D | CFO | P - Purchase | $4.24 | +2,000 | 143,927 | +1% | +$8,480 | ||||||
2026-05-15 | TLSI | Trisalus Life Sciences, Inc. | Marshak Richard | Chief Commercial Officer | S - Sale | $2.67 | -543 | 125,101 | 0% | -$1,450 | ||||||
2026-05-15 | INSP | Inspire Medical Systems, Inc. | Rondoni John | See Remarks | S - Sale | $43.28 | -2,641 | 27,165 | -9% | -$114,302 | ||||||
2026-05-15 | OBIO | Orchestra Biomed Holdings, Inc. | Aryeh Jason | Dir | P - Purchase | $3.90 | +8,971 | 117,453 | +8% | +$34,987 | ||||||
2026-05-15 | OBIO | Orchestra Biomed Holdings, Inc. | Hochman David P | See Remarks | P - Purchase | $3.77 | +5,000 | 1,507,651 | 0% | +$18,850 | ||||||
| D | 2026-05-14 | GKOS | Glaukos Corp | Kliman Gilbert H | Dir | S - Sale+OE | $140.76 | -5,000 | 35,528 | -12% | -$703,800 | |||||
2026-05-15 | KMTS | Kestra Medical Technologies, Ltd. | Webster Brian Daniel | See Remarks | S - Sale | $20.96 | -15,000 | 334,786 | -4% | -$314,329 | ||||||
2026-03-14 | BJDX | Bluejay Diagnostics, Inc. | Wurth Douglas Clark | Dir | P - Purchase | $2.00 | +12,500 | 12,608 | >999% | +$25,000 | ||||||
2026-03-14 | BJDX | Bluejay Diagnostics, Inc. | Dey Indranil | Pres, CEO | P - Purchase | $2.00 | +12,500 | 12,649 | >999% | +$25,000 | ||||||
2026-03-14 | BJDX | Bluejay Diagnostics, Inc. | Chase Donald R | Dir | P - Purchase | $2.00 | +12,500 | 12,525 | >999% | +$25,000 | ||||||
2026-03-14 | BJDX | Bluejay Diagnostics, Inc. | Zeidman Fred S | Dir | P - Purchase | $2.00 | +12,500 | 12,500 | New | +$25,000 | ||||||
2026-03-14 | BJDX | Bluejay Diagnostics, Inc. | Dey Svetlana | Dir | P - Purchase | $2.00 | +12,500 | 12,628 | >999% | +$25,000 | ||||||
2026-05-15 | TLSI | Trisalus Life Sciences, Inc. | Wahlstrom Mats | Dir | P - Purchase | $2.53 | +60,000 | 2,962,030 | +2% | +$151,800 | ||||||
2026-05-15 | TLSI | Trisalus Life Sciences, Inc. | Stansky Michael P | Dir | P - Purchase | $2.50 | +610,000 | 1,640,420 | +59% | +$1,525,000 | ||||||
2026-05-15 | TLSI | Trisalus Life Sciences, Inc. | Szela Mary T | CEO, Pres | P - Purchase | $2.59 | +39,682 | 1,065,215 | +4% | +$102,776 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |